• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners

    9/22/25 11:30:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $RVTY alert in real time by email

    NEW YORK, Sept. 22, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global lab automation market is observing significant growth due to technological advancements, regulatory & quality compliance, and demand for efficiency & throughput.

    (PRNewsfoto/The Insight Partners)

    The report runs an in-depth analysis of market trends, key players, and future opportunities. The lab automation market generally comprises a vast array of types, equipment, applications, end users, and geography, which are expected to register strength in the coming years.

    Check valuable insights in the Lab Automation Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com/sample/TIPHE100001249/

    Overview of Report Findings

    1.      Market Dynamics and Insights: Laboratories are under pressure to improve operational efficiency while remaining agile in the face of evolving scientific needs, shifting research priorities, and budgetary constraints. Traditional automation systems, which were rigid and monolithic, limited labs' ability to adapt quickly or expand capabilities incrementally.

    In contrast, the new generation of modular automation platforms offers a flexible, building-block approach, allowing laboratories to start small and scale up as demand increases or workflows evolve. This shift reduces the initial capital expenditure and lowers integration complexity, making automation more accessible to facilities, including mid-sized labs, academic research centers, and clinical testing environments.

    By integrating seamlessly with legacy infrastructure and advanced digital tools, these systems enable labs to future-proof their operations and improve return on investment over time. Integrated and scalable systems are central to transforming labs into smart, connected environments. These platforms work cohesively with LIMS, ELNs, and data analytics software, enabling end-to-end automation and real-time decision-making. With increasing emphasis on personalized medicine, high-throughput screening, and data-intensive workflows, labs must be equipped to handle complex processes efficiently and with minimal downtime.

    Modular automation allows for rapid configuration changes, supports parallel workflows, and simplifies maintenance, ensuring operational continuity during upgrades or reconfigurations. The demand for integrated, scalable automation systems is projected to rise, driven by laboratories' pursuit of flexibility, digitalization, and long-term operational resilience. Vendors prioritizing modularity, interoperability, and ease of integration will be best positioned to lead in this evolving market landscape.

    2.      Regional Insights: The Middle East & Africa presents a unique lab automation landscape characterized by extreme diversity in infrastructure, economic conditions, and healthcare priorities. In the Middle East, wealthy Gulf Cooperation Council (GCC) countries such as Saudi Arabia, UAE, Qatar, and Kuwait are investing in smart healthcare infrastructure as part of long-term strategic visions such as Saudi Vision 2030 and Dubai Health Strategy 2021. These countries integrate advanced lab automation, AI, and digital platforms to improve healthcare delivery, attract medical tourism, and support research excellence.

    Institutions such as Cleveland Clinic Abu Dhabi, King Faisal Specialist Hospital, and Pure Health have adopted high-throughput automation solutions from Roche, Siemens, Thermo Fisher, and BD, often tailored to local needs with multilingual interfaces and regional service support. In Africa, South Africa stands out as the most advanced market, with national reference labs under NHLS and private chains such as PathCare deploying automation for infectious disease testing, routine diagnostics, and research.

    Kenya, Nigeria, Egypt, and Ghana focus on affordable, modular automation systems, often delivered through partnerships with NGOs, global health organizations, or aid agencies. Technologies such as Cepheid's GeneXpert are effective in decentralized, disease-specific testing programs. Challenges in the MEA include limited technical training, fragmented logistics, regulatory inconsistencies, and a need for more local service capabilities. However, with increasing government healthcare investment, international collaborations, and the growth of digital health ecosystems, MEA holds significant untapped potential for lab automation expansion.

    3.      Geographical Insights: North America is expected to dominate the lab automation market with the highest market share in 2024.

    Market Segmentation

    •         The lab automation market is bifurcated based on type into equipment and software.

    •         Per equipment, the lab automation market is divided into automated workstations, liquid handling systems, robotic systems, microplate readers, automated storage and retrieval systems (ASRS), and others.

    •         The lab automation market is segmented by application into clinical diagnostics, drug discovery, proteomics solutions, and genomics solutions.

    •         Based on end user, the market is categorized into hospitals, diagnostic centers, pharmaceutical companies, contract research organizations (CROS), and educational and research institutions.

    •         The lab automation market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America.

     

    Get Research Sample Copy of the Lab Automation Market: https://www.theinsightpartners.com/sample/TIPHE100001249 

    Competitive Strategy and Development

    • Key Players: A few major companies operating in the lab automation market include Thermo Fisher Scientific Inc.; Siemens AG; Danaher Corp; Honeywell International Inc; Agilent Technologies Inc; Revvity Inc; Analytik Jena GmbH+Co. KG; Abbott Laboratories; Eppendorf SE; and bioMerieux SA.
    • Trending Topics: AI-Driven Workflow Optimization, Modular & Scalable Automation Systems, Integration of Robotics & Smart Lab Equipment, Cloud-Based Data Management, and Lab-as-a-Service (LaaS) Models, among others.

    Global Headlines on the Lab Automation Market

    •         "Revvity, Inc. (NYSE:RVTY) announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT TB test. The Auto-Pure 2400 platform is easy to use and designed to provide efficient lab workflows. When the accuracy of the T-SPOT TB test is combined with the efficiency of the Auto-Pure 2400 system, labs, clinicians and ultimately patients benefit from the resultant powerful solution."

    •         "Thermo Fisher Scientific Inc. launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS). The launch includes a new single quadrupole Thermo Scientific iCAP MSX ICP-MS and triple quadrupole Thermo Scientific iCAP MTX ICP-MS designed for environmental, food, industrial and research labs to analyze routine and challenging trace elements to detect and mitigate harmful substances."

    Get Premium Copy of Lab Automation Market Size and Growth Report by 2031 at:  https://www.theinsightpartners.com/buy/TIPHE100001249

    Conclusion

    Lab Automation involves the use of advanced technologies, such as robotics, software, and integrated systems, to streamline and enhance laboratory workflows in areas including sample handling, diagnostics, drug discovery, and data analysis. It enables laboratories to increase throughput, improve accuracy, reduce human error, and optimize operational efficiency. Key drivers of growth in the lab automation market include the rising demand for high-throughput testing, increasing adoption of AI and machine learning, growing need for reproducibility in research, and the pressure to reduce operational costs in healthcare and pharmaceutical sectors.

    The report from The Insight Partners provides several stakeholders, including lab equipment manufacturers, software vendors, research organizations, healthcare providers, and regulatory bodies, with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.

    Trending Related Reports:

    •         Lab Automation in Protein Engineering Market Size, Trends, Shares, and Forecast – 2031

    •         Lab Automation In Genomics Market Size, Trends, Shares, and Forecast – 2031

    •         Lab Automation in Drug Discovery Market Size, Share, Scope 2031

    •         Lab Automation in Clinical Diagnostics Market Size, Share 2031

    •         Total Lab Automation Market Scope 2031

    About Us:

    The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

    Contact Us:

    If you have any queries about this report or if you would like further information, please get in touch with us:

    Contact Person: Ankit Mathur

    E-mail: [email protected]

    Phone: +1-646-491-9876

    Also Available in : Korean | German | Japanese | French | Arabic | Chinese | Italian | Spanish

    Logo: https://mma.prnewswire.com/media/1586348/5449703/The_Insight_Partners_Logo.jpg

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lab-automation-market-is-projected-to-reach-us8-71-billion-by-2031-at-cagr-of-6-3--the-insight-partners-302563120.html

    SOURCE The Insight Partners

    Get the next $RVTY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RVTY

    DatePrice TargetRatingAnalyst
    5/1/2025$115.00Neutral → Buy
    UBS
    1/10/2025$130.00Outperform → Mkt Perform
    Bernstein
    12/13/2024$138.00Neutral → Buy
    BofA Securities
    10/15/2024$125.00 → $140.00Equal Weight → Overweight
    Barclays
    8/28/2024$130.00Equal Weight
    Wells Fargo
    7/8/2024$125.00Outperform
    Leerink Partners
    6/3/2024$115.00Hold
    Jefferies
    1/16/2024$105.00 → $125.00Buy → Neutral
    UBS
    More analyst ratings

    $RVTY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis

    New software further strengthens Revvity's market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities—reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery. "Our Living Image Synergy AI software marks a significant leap forward in p

    9/29/25 8:00:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Lab Automation Market is Projected To Reach US$8.71 Billion By 2031 at CAGR of 6.3% | The Insight Partners

    NEW YORK, Sept. 22, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global lab automation market is observing significant growth due to technological advancements, regulatory & quality compliance, and demand for efficiency & throughput. The report runs an in-depth analysis of market trends, key players, and future opportunities. The lab automation market generally comprises a vast array of types, equipment, applications, end users, and geography, which are expected to register strength in the coming years. Check valuable insights in the Lab Automation Market report. You can easily get a sample PDF of the report - https://www.theinsightpartners.com

    9/22/25 11:30:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

    Combination of Revvity's proprietary Pin-point platform and Profluent's AI-engineered proteins created to inspire accelerated development of novel gene editing therapies Revvity, Inc. (NYSE:RVTY) announced a strategic collaboration with Profluent, bringing together a range of its novel AI-engineered enzymes with Revvity's established Pin-pointTM base editing platform. The result is simplified access for customers to a therapeutically relevant base editing toolkit. This new Pin-point configuration allows for increased precision and efficiency, with some combinations being precise to single nucleotide edits without bystander editing. Additionally, the Pin-point platform's modular design h

    9/22/25 8:00:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RVTY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Revvity upgraded by UBS with a new price target

    UBS upgraded Revvity from Neutral to Buy and set a new price target of $115.00

    5/1/25 7:42:49 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity downgraded by Bernstein with a new price target

    Bernstein downgraded Revvity from Outperform to Mkt Perform and set a new price target of $130.00

    1/10/25 8:41:17 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity upgraded by BofA Securities with a new price target

    BofA Securities upgraded Revvity from Neutral to Buy and set a new price target of $138.00

    12/13/24 8:43:02 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RVTY
    SEC Filings

    View All

    SEC Form 10-Q filed by Revvity Inc.

    10-Q - REVVITY, INC. (0000031791) (Filer)

    8/5/25 4:10:32 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - REVVITY, INC. (0000031791) (Filer)

    7/28/25 7:12:47 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 11-K filed by Revvity Inc.

    11-K - REVVITY, INC. (0000031791) (Filer)

    6/20/25 2:18:15 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RVTY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Gonzales Anita covered exercise/tax liability with 149 shares, decreasing direct ownership by 3% to 4,340 units (SEC Form 4)

    4 - REVVITY, INC. (0000031791) (Issuer)

    9/17/25 4:05:09 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Officer Krakowiak Maxwell covered exercise/tax liability with 559 shares, decreasing direct ownership by 4% to 12,217 units (SEC Form 4)

    4 - REVVITY, INC. (0000031791) (Issuer)

    9/17/25 4:05:14 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Michas Alexis P sold $44,505 worth of shares (500 units at $89.01) (SEC Form 4)

    4 - REVVITY, INC. (0000031791) (Issuer)

    8/28/25 4:05:04 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RVTY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Revvity Inc.

    SC 13G/A - REVVITY, INC. (0000031791) (Subject)

    11/14/24 4:30:07 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Revvity Inc.

    SC 13G/A - REVVITY, INC. (0000031791) (Subject)

    11/14/24 1:28:28 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Revvity Inc.

    SC 13G - REVVITY, INC. (0000031791) (Subject)

    11/14/24 1:22:34 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $RVTY
    Financials

    Live finance-specific insights

    View All

    Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina

    Facility designed to advance the next generation of imaging systems Revvity, Inc. (NYSE:RVTY), today announced the opening of its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, the heart of the state's Research Triangle. The center consolidates Revvity's expertise and resources to drive R&D innovation and create the next generation of imaging systems backed by AI software tools and other advanced technologies. The new facility is staffed by R&D teams from across the organization, including software, hardware, and applied biology/applications teams, as well as those specialized in machine learning, optical, microCT, and ultrasound. Combined, these teams will hel

    9/2/25 8:00:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity Announces Financial Results for the Second Quarter of 2025

    Revenue of $720 million; 4% reported growth; 3% organic growth GAAP EPS of $0.46; Adjusted EPS from continuing operations of $1.18 Updates full year 2025 guidance Revvity, Inc. (NYSE:RVTY), today reported financial results for the second quarter ended June 29, 2025. The Company reported GAAP earnings per share of $0.46, as compared to $0.45 in the same period a year ago. Revenue for the quarter was $720 million, as compared to $692 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $91 million, as compared to $86 million for the same period a year ago. GAAP operating profit margin from continuing operations was 12.6% as a

    7/28/25 6:00:00 AM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Revvity Board Declares Quarterly Dividend

    The Board of Directors of Revvity (NYSE:RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on November 7, 2025 to all shareholders of record at the close of business on October 17, 2025. About Revvity At Revvity, "impossible" is inspiration, and "can't be done" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screenin

    7/24/25 4:05:00 PM ET
    $RVTY
    Biotechnology: Laboratory Analytical Instruments
    Industrials